As hospital systems get bigger, they are putting distance between their doctors and drug sellers, making it harder for pharmaceutical companies to get quick acceptance of newly approved medicines and putting pressure on profits. As a result, the pharmaceutical industry is shifting its sales efforts from doctors to the institutions they work for.
As doctors lose clout, drug firms redirect the sales call
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.